Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in DBVT held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | MPM Oncology Impact Management LP | 5.2M | $108.9M | +423.0% | 8.808% | 8.41% |
| 2 | Vivo Capital, LLC | 2.7M | $55.7M | +8.4% | 4.507% | 4.65% |
| 3 | Artisan Partners Limited Partnership | 2.2M | $46.4M | -32.9% | 3.750% | 0.08% |
| 4 | Siren, L.L.C. | 1.9M | $38.8M | 0.0% | 3.138% | 1.08% |
| 5 | BAKER BROS. ADVISORS LP | 1.5M | $30.5M | 0.0% | 2.469% | 0.18% |
| 6 | ADAR1 Capital Management, LLC | 1.0M | $21.2M | β | 1.711% | 1.32% |
| 7 | PERCEPTIVE ADVISORS LLC | 964K | $20.1M | β | 1.629% | 0.40% |
| 8 | Patient Square Capital LP | 694K | $14.5M | +93.2% | 1.172% | 2.57% |
| 9 | Octagon Capital Advisors LP | 574K | $12.0M | 0.0% | 0.970% | 1.33% |
| 10 | Redmile Group, LLC | 491K | $10.3M | -10.6% | 0.830% | 0.68% |
| 11 | MILLENNIUM MANAGEMENT LLC | 319K | $6.7M | -50.2% | 0.539% | 0.00% |
| 12 | Atika Capital Management LLC | 271K | $5.7M | +31.1% | 0.458% | 0.85% |
| 13 | Elmind Capital, LP | 265K | $5.5M | β | 0.448% | 1.57% |
| 14 | BALYASNY ASSET MANAGEMENT LLC | 233K | $4.9M | -0.7% | 0.394% | 0.02% |
| 15 | AMERIPRISE FINANCIAL INC | 231K | $4.8M | β | 0.391% | 0.00% |
| 16 | Yiheng Capital Management, L.P. | 170K | $3.6M | -73.4% | 0.287% | 1.54% |
| 17 | NEW YORK STATE COMMON RETIREMENT FUND | 168K | $3.5M | -24.6% | 0.284% | 0.00% |
| 18 | BOOTHBAY FUND MANAGEMENT, LLC | 163K | $3.4M | 0.0% | 0.276% | 0.09% |
| 19 | MORGAN STANLEY | 146K | $3.1M | +19.3% | 0.247% | 0.00% |
| 20 | Russell Investments Group, Ltd. | 129K | $2.7M | β | 0.217% | 0.00% |
| 21 | Ikarian Capital, LLC | 525K | $2.2M | 0.0% | 0.887% | 0.23% |
| 22 | Dorsey Wright & Associates | 103K | $2.1M | β | 0.173% | 0.27% |
| 23 | Ishara Investments LP | 103K | $2.1M | β | 0.173% | 2.03% |
| 24 | ENVESTNET ASSET MANAGEMENT INC | 96K | $2.0M | +327.5% | 0.162% | 0.00% |
| 25 | UBS Group AG | 80K | $1.7M | -67.5% | 0.134% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in DBVT β a direct measure of their conviction.
Filings activity in DBVT during Q1 2026, grouped by how each filer changed its position.
8 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 70 | +35% | 41.24% | +11.92 pp | $425M | +41% |
| Q4 2025 | 52 | +58% | 29.32% | +23.00 pp | $302M | +364% |
| Q3 2025 | 33 | +14% | 6.32% | 0.10 pp | $65M | 1.5% |
| Q2 2025 | 29 | +61% | 6.42% | +4.79 pp | $66M | +293% |
| Q1 2025 | 18 | 5.3% | 1.63% | +0.81 pp | $17M | +99% |
| Q4 2024 | 19 | 27% | 0.82% | 5.62 pp | $8M | 87% |
| Q3 2024 | 26 | 16% | 6.44% | +4.46 pp | $66M | +225% |
| Q2 2024 | 31 | β | 1.98% | β | $20M | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying DBVT stock.
Based on Q1 2026 13F filings, institutional ownership of DBV Technologies S.A. stands at 41.2%, held across 70 reporting institutions.
MPM Oncology Impact Management LP is the largest reported institutional holder of DBVT, with approximately 5,213,361 shares worth $0.11B as of Q1 2026.
Yes β 1 widely-followed marquee investor appear among the top 25 institutional holders of DBVT, including MILLENNIUM MANAGEMENT LLC.
Our composite Smart Money Score for DBVT is 66 out of 100 (Bullish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
29 institutions opened new positions in DBVT during Q1 2026, while 11 fully exited. 31 added to existing positions and 10 trimmed.
DBVT institutional ownership rose by 11.92 percentage points quarter-over-quarter, with a net change of +18 holders.
The top 10 institutions account for 84.3% of all reported 13F value in DBVT, and the top 25 account for 97.0%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
DBV Technologies S.A. (DBVT) Institutional Ownership